Daniel Meyer

CEO at CellChorus

Daniel Meyer is an early stage entrepreneur and investor with experience across software, hardware and services companies in life sciences and information technology. He was the Chief Operating Officer and a board member of Genospace, an information platform for applied molecular and precision medicine, until its acquisition by HCA Healthcare (NYSE:HCA).

Dan was a member of the venture capital investment teams at Arboretum Ventures and PJC.vc, where he covered investments in life science research products, medical device, and digital health. He was a member of the healthcare investment banking group at Credit Suisse First Boston. He holds a B.A. in mathematics and economics from Middlebury College and an M.B.A. from the Tuck School of Business at Dartmouth.

Links


Org chart

Sign up to view 4 direct reports

Get started